Why are we begging PUMA desperately?

Discussion in 'Spectrum Pharmaceuticals' started by Anonymous, Jul 11, 2017 at 9:20 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Raj is now desperately asking PUMA Biotech to buy sppi's Poziotinib bcoz after PUMA's Neratinib approval Poziotinib will be useless.

    While tracking Poziotinib & Rolantis (which SPPI got from Hanmi,Korea), I as an analyst and student of pharma could not find any positive topline phase-1 data news from hanmi. Its funny that without that Sppi says these two drugs are big. Try yourself and publish a link if you find one from 2010 or 2011 when phase 1 trials concluded.
     

  2. anonymous

    anonymous Guest

    you are quite prolific and use bcoz which really identifies your posts as nobody abbreviates because like that...just saying
    ...HOWEVER mostly your posts are VERY true
     
  3. anonymous

    anonymous Guest

    I heard , Tom is shood towards PUMA by Raj and asked him to get PUMAs Neratinib marketing rights. Tom Riga seems to be in do or die situation. PUMA will never talk to us. Pramod Gupta has already asked Raj to get rid of Tom.
     
  4. anonymous

    anonymous Guest

    What? Marketing rights for Neratinib? Then, what will happen to Poziotinib.

    For past 2 years SPPI kept saying there is nothing better then Poziotinib and now this...!!!!!

    PUMA must be laughing on SPPIsacrcastic (laugh) (laugh) (laugh)
     
  5. anonymous

    anonymous Guest

    what happens when all are YES men to Raj- perspective gets lost... he needed to keep folks around that would challenge things and open minds to other ideas... that is what LEADERS do !
     
  6. anonymous

    anonymous Guest

    Raj is awesome. Get back to the cellar troll.
     
  7. anonymous

    anonymous Guest

    http://cancerres.aacrjournals.org/content/76/4_Supplement/P4-13-19
     
  8. anonymous

    anonymous Guest

    http://cancerres.aacrjournals.org/content/76/4_Supplement/P4-13-19
     
  9. anonymous

    anonymous Guest

    Well spoken like a YES MAN
     
  10. anonymous

    anonymous Guest

    Stop posting paid publications. Anytime you see an Indian on SPPI earnings call; he/she is paid by Raj (CEO)

    Where is topline phase 1 publication from hanmi ? where these products came from!. These were failed products and Raj got it under $1 million. Now, why would someone sell a better product to SPPI. Someone contact Hanmi people and you will get the truth.

    " Raj is now desperately asking PUMA Biotech to buy sppi's Poziotinib bcoz after PUMA's Neratinib approval Poziotinib will be useless.

    While tracking Poziotinib & Rolantis (which SPPI got from Hanmi,Korea), I as an analyst and student of pharma could not find any positive topline phase-1 data news from hanmi. Its funny that without that Sppi says these two drugs are big. Try yourself and publish a link if you find one from 2010 or 2011 when phase 1 trials concluded."
     
  11. anonymous

    anonymous Guest

    Great hit ..just a blunt Truth
     
  12. anonymous

    anonymous Guest

    Why would SPPI do that? That is insane. They will lose all respect in market.
     
  13. anonymous

    anonymous Guest

    too late for that
     
  14. anonymous

    anonymous Guest

     
  15. anonymous

    anonymous Guest

    Except clearly none of you have been paying attention to the new Pozi direction. Do you know how to read press releases? Leave if you want, but you're blind not to see the promise in this product. Guess you're very unaware when it comes to the NEW science/indication. Wake up, seriously! Clearly some of you need some scientific education. Stop insulting your managers and executives! Just leave - you'd be doing all of us a favor. Where is your passion, drive, or appreciation for this job? You signed up for it and lucky to even have it. Count your blessings or move on. Nobody is asking you to stay.
     
  16. anonymous

    anonymous Guest

    Now, begging PUMA won't help. They know SPPI is a shallow hole. Raj got all these Indians who constantly failed SPPI at all levels. Anil Hiteshi always talks about shit behind his backs while Gajanan looks like an off joker who failed miserably in ODAC. Pramod is slightly better but people see him as a low grade as he continue to work among all these jokers.

    Have you ever spoken to Shiv Kapoor, their market guy? VP of investor relations. He was just a writing analyst at an investment company and Raj told in one of his meetings that he hired him because Shiv used to write good about SPPI, seriously !
     
  17. anonymous

    anonymous Guest

    I heard sm1 complained and their books might get opened up by IRS or SEC. They way Raj has given out of turn money to his Indian joker's for buying homes while he thrashed local Americans badly. Reason to as simple, to make as many indian spy in SPPI working for him and ousting local American workforce.

    Sm1 told me Raj even brought a joker named Chander Vasandani from India on H1b visa and made him Director-Clinical Operations. Seriously? Guy can't even speak English. If you ever come to SPPI then you should talk to this chap and you will giggle :)

    It's sad that our country has such folks who are all nepotism and nothing else. President Trump; would you please do something about this ?
     
  18. anonymous

    anonymous Guest

    Its funny..Raj is fond of these Indians it's sure they will sell him up for money and better career. I saw a huge list of names on Yahoo finance forum. Go and read old posts.
     
  19. anonymous

    anonymous Guest

    It seems News is coming out soon on Rolantis enrollment completion to boost stock. Whether rolantis drug works or not SPPI is in full planning to boost stock by playing news game over the period of next 1 year or so. I am